| Literature DB >> 32404058 |
Ahmed A Ahmed1, Zafar Rasheed2, Tarek Salem3, Mohammed S Al-Dhubaibi4, Ahmad A Al Robaee4, Abdullateef A Alzolibani4.
Abstract
BACKGROUND: Cutaneous leishmaniasis (CL) is well linked with immunogenetic factors. This study was undertaken to test the association of TNF-α - 308 and IFN-γ + 874 gene polymorphisms with the susceptibility of Leishmania (L) species among CL patients in central region of Saudi Arabia.Entities:
Keywords: Cutaneous leishmaniasis; Gene polymorphism; IFN-γ; L. major; L. tropica; TNF-α
Year: 2020 PMID: 32404058 PMCID: PMC7218653 DOI: 10.1186/s12881-020-01043-9
Source DB: PubMed Journal: BMC Med Genet ISSN: 1471-2350 Impact factor: 2.103
Demographic details of studied cutaneous leishmaniasis subjects
| Parameters | Results |
|---|---|
| Total number of studied | 169 |
| Patients age (mean ± SD., years) | 34.1 ± 3.5 |
| Gender | 91 males; 78 females |
| Disease duration (mean ± SD., months) | 55.91 ± 34.7 |
| Sites of lesions | Limb, facial or skill |
| No. of lesions | 1–14 |
| 102 | |
| 59 | |
| 08 | |
| Total number of healthy human controls | 199 |
| Age of controls (mean ± SD., years) | 36.8 ± 7.2 |
| Gender of controls | 106 males; 93 females |
Primer sequences used for TNF-α A/G and INF-γ T/A genotypes and allelic polymorphisms in skin biopsies of leishmaniasis patients
| 1 | Forward Primer (Common) | 5`-TCTCGGTTTCTTCTCCATCG-3` |
| 2 | Reverse Primer 1 (G allele) | 5`-ATAGGTTTTGAGGGGCATGG-3 |
| 3 | Reverse Primer 2 (A allele) | 5`-ATAGGTTTTGAGGGGCATGA-3` |
| 1 | Forward Primer (Common) | 5`-TCAACAAAGCTGATACTCCA-3` |
| 2 | Reverse Primer 1 (T allele) | 5`-TTCTTACAACACAAAATCAAATCT-3 |
| 3 | Reverse Primer 2 (A allele) | 5`-TTCTTACAACACAAAATCAAATCA-3 |
Fig. 1TNF-α − 308 G/A polymorphism in CL patients. Lane M indicates for DNA ladder 100 bp, lanes 1 and 1’represent GA genotype for sample 1, lanes 2 and 2` represent GA for sample 2, lanes 3 and 3` represent GG genotype for sample 3, lanes 4 and 4` represent AA genotype for sample 4, lanes 5 and 5` represent GG genotype for sample 5 and lanes 6 and 6` represent GG genotype for sample 6. All TNF-α − 308 G/A genotype polymorphism detected at the same size (184 bp) by the amplification refractory mutation system
Genotype frequencies of TNF-α-308 G/A in different species of leishmaniasis and healthy human controls
| Genotypes | ||
| GG | 60 (58.8) | 130 (65.3) |
| GA | 39 (38.2) | 65 (32.7) |
| AA | 3 (3.0) | 4 (2.0) |
| Alleles | ||
| G | 159 (78) | 325 73 (81.7) |
| A | 45 (22) | 73 (18.3) |
| Statistics | ||
| AA+GA vs. GG (dominant) | OR (95%CI) 1.31 [0.8 to 2.2] | |
| AA vs. GG + GA (recessive) | OR (95%CI) 1.5 [0.3 to 6.7] | |
| A allele vs. G allele | OR (95%CI) 1.3 [0.8 to 1.9] | |
| Genotypes | ||
| GG | 35 (59.3) | 130 (65.3) |
| GA | 24 (40.7) | 65 (32.7) |
| AA | 0 (0) | 4 (2) |
| Alleles | ||
| G | 91 (79.6) | 325 (81.7) |
| A | 27 (20.4) | 73 (18.3) |
| Statistics | ||
| AA+GA vs. GG (dominant) | OR (95%CI) 1.3 [0.7 to 2.3] | |
| AA vs. GG + GA (recessive) | OR (95%CI) 0.4 [0.02 to 7.1] | |
| A allele vs. G allele | OR (95%CI) 2.2 [1.4 to 3.4] | |
| Genotypes | ||
| GG | 5 (62.5) | 130 (65.3) |
| GA | 3 (37.5) | 65 (32.7) |
| AA | 0 (0) | 4 (2) |
| Alleles | ||
| G | 13 (77.4) | 325 (81.7) |
| A | 3 (22.6) | 73 (18.3) |
| Statistics | ||
| ND | ND | ND |
| Genotypes | ||
| GG | 100 (59.2) | 130 (65.3) |
| GA | 66 (39.1) | 65 (32.7) |
| AA | 3 (1.7) | 4 (2) |
| Alleles | ||
| G | 266 (78.7) | 325 (81.7) |
| A | 72 (21.3) | 73 (18.3) |
| Statistics | ||
| AA+GA vs. GG (dominant) | OR (95%CI) 1.3 [0.9 to 2.0] | |
| AA vs. GG + GA (recessive) | OR (95%CI) 0.9 [0.2 to 4.0] | |
| A alleles vs. G allele | OR (95%CI) 1.2 [0.8 to 1.7] | |
P*significant
P** highly significant
Fig. 2IFN-γ + 874 A/T polymorphism in CL patients. Lane M indicate DNA ladder 100 bp, lanes 1 and 1’represent AA genotype for sample 1, lanes 2 and 2` represent AT genotype for sample 2, lanes 3 and 3` represent TT genotype for sample 3, lanes 4 and 4` represent AT genotype for sample 4, lanes 5 and 5` represent AA genotype for sample 5 and lanes 6 and 6` represent TT genotype for sample 6. All IFN-γ +874 A/T genotypes detected at the same size (263 bp) by the amplification refractory mutation system
Genotype frequencies of INF-γ + 874 A/T in different species of leishmaniasis and healthy human controls
| Genotypes | ||
| AA | 28 (27.5) | 76 (38.2) |
| AT | 59 (57.8) | 111 (55.8) |
| TT | 15 (14.7) | 12 (6.0) |
| Alleles | ||
| A | 115 (56.4) | 263 (66.1) |
| T | 89 (43.6) | 135 (33.9) |
| Statistics | ||
| TT + AT vs. AA (dominant) | OR (95%CI)1.4 [0.8 to 2.4] | |
| TT vs. AA+AT (recessive) | OR (95%CI) 2.7 [1.2 to 5.9] | |
| T allele vs. A allele | OR (95%CI)1.5 [1.07 to2.13] | |
| Genotypes | ||
| AA | 18 (30.5) | 76 (38.2) |
| AT | 33 (56) | 111 (55.8) |
| TT | 8 (13.5) | 12 (6.0) |
| Alleles | ||
| A | 69 (58.5) | 263 (66.1) |
| T | 49 (41.5) | 135 (33.9) |
| Statistics | ||
| TT + AT vs. AA (dominant) | OR (95%CI)1.4 [0.8 to 2.6] | |
| TT vs. AA+AT (recessive) | OR (95%CI) 2.4 [0.9 to 6.2] | |
| T allele vs. A allele | OR (95%CI)1.4 [0.9 to 2.1] | |
| Genotypes | ||
| AA | 3 (37.5) | 76 (38.2) |
| AT | 4 (50) | 111 (55.8) |
| TT | 1 (12.5) | 12 (6.0) |
| Alleles | ||
| A | 10 (62.5) | 263 (66.1) |
| T | 6 (37.5) | 135 (33.9) |
| Statistics | ||
| NA | NA | NA |
| Genotypes | ||
| AA | 49 (29) | 76 (38.2) |
| AT | 96 (56.8) | 111 (55.8) |
| TT | 24 (14.2) | 12 (6.0) |
| Alleles | ||
| A | 194 (57.4) | 263 (66.1) |
| T | 144 (42.6) | 135 (33.9) |
| Statistics | ||
| TT + AT vs. AA (dominant) | OR (95%CI) 1.5 [1.0 to 2.3] | |
| TT vs. AA+AT (recessive) | OR (95%CI) 2.5 [1.2 to 5.3] | |
| T allele vs. A allele | OR (95%CI) 1.4 [1.07 to2.0] | |
P* significant
P** highly significant
Synergistically combined genotype frequencies of TNF-α-308 G/A and INF-γ 874 A/T in different species of leishmaniasis and healthy human controls
| Healthy human controls | OR (95%CI) | |||
|---|---|---|---|---|
| Low (GG) | 60 (58.8) | 130 (65.3) | ||
| High (GA + AA) | 42 (41.2) | 69 (34.7) | ||
| Low (AA) | 28 (27.5) | 76 (38.2) | ||
| High (AT+TT) | 74 (72.5) | 123 (61.8) | ||
| Low/ low | 18 (17.6) | 51 (25.6) | 0.1 | 0.6 (0.3 to1.1) |
| Low/ high | 42 (41.2) | 89 (44.7) | 0.5 | 0.8 (0.5 to 1.4) |
| High/ low | 10 (9.8) | 25 (12.6) | 0.4 | 0.7 (0.3 to 1.6) |
| High/ high | 32 (31.4) | 34 (17.1) | 2.2 (1.2 to 3.8) | |
| Low (GG) | 35 (59.3) | 130 (65.3) | ||
| High (GA + AA) | 24 (40.7) | 69 (34.7) | ||
| Low (AA) | 18 (30.5) | 76 (38.2) | ||
| High (AT+TT) | 41 (69.5) | 123 (61.8) | ||
| Low/ low | 15 (25.4) | 51 (25.6) | 0.7 | 0.8 (0.3 to 1.7) |
| Low/ high | 20 (33.9) | 89 (44.7) | 0.1 | 0.6 (0.3 to 1.1) |
| High/ low | 3 (5.1) | 25 (12.6) | 0.1 | 0.3 (0.1 to 1.3) |
| High/ high | 21 (35.6) | 34 (17.1) | 2.7 (1.4 to 5.1) | |
| Low (GG) | 100 (59.2) | 130 (65.3) | ||
| High (GA + AA) | 69 (40.8) | 69 (34.7) | ||
| Low (AA) | 49 (29.0) | 76 (38.2) | ||
| High (AT+TT) | 120 (71.0) | 123 (61.8) | ||
| Low/ low | 36 (21.3) | 51 (25.6) | 0.3 | 0.7 (0.4 to 1.2) |
| Low/ high | 64 (37.9) | 89 (44.7) | 0.1 | 0.7 (0.4 to 1.1) |
| High/ low | 15 (8.9) | 25 (12.6) | 0.2 | 0.6 (0.3 to 1.3) |
| High/ high | 54 (31.9) | 34 (17.1) | 2.2 (1.2 to 3.7) | |
P** highly significant